Global unbiased metabolomic analysis was conducted to identify any changes in levels of metabolites that occurred following CCL5 treatment of the primary MMTV-PyMT tumour cells for 3 and 6 h (figure 6a). This evidence concerns the gene CCL5 and neoplasm.